info@seagull-health.com
SeagullHealth
语言:
search
HomepageDrugsSyprine(Trientine)

Syprine(Trientine)

Names
Cuvrior,曲恩汀
Indicatons
Treatment of stable Wilson’s disease in decoppered, penicillamine-tolerant adults.
Price:
Manufacturer:
Merck
Dosage form:
CAPSULE
Validity period:
24 months

Reminder: The outer packaging is for reference only, please purchase and use under the guidance of a pharmacist. For read by medical and pharmaceutical professionals only.

Syprine(Trientine) Instructions:Uses,Dosage, Side Effects

CUVRIOR (trientine tetrahydrochloride) is an oral tablet medication classified as a copper chelator. Its active ingredient functions by binding to copper, facilitating its removal from the body primarily through urinary excretion. 

It is specifically formulated for use in a defined adult patient population with a stable form of Wilson's disease who have previously been decoppered and are tolerant to penicillamine therapy. The tablets are oblong, yellow, film-coated, and functionally scored.

Generic name
Syprine(Trientine)
English name
Trientine
Alternative Names
Cuvrior,曲恩汀
Drug prices
Indications

CUVRIOR is indicated for the treatment of adult patients with stable Wilson's disease who have been decoppered and are tolerant to penicillamine.

Therapeutic Target
Copper ions (chelating agent)
Active Ingredients
Trientine
Dosage Form
CAPSULE
Specifications
250mg * 100 capsules/box
Dosage and Administration

The recommended starting total daily dose ranges from 300 mg to 3,000 mg, administered orally in two divided doses.

    Related Columns
    Recommended articles
    Related articles
    Departments
    Oncology
    Hematology
    Immunology
    Hepatology
    Endocrinology
    Pulmonology
    Neurology
    Cardiology
    Gastroenterology
    Dermatology
    New Articles
    Dosage and Administration, Recommended Dosage of Capmatinib (Tabrecta)
    What Are the Indications for Capmatinib (Tabrecta)?
    What Are the Purchase Channels for Capmatinib (Tabrecta)?
    Adverse Reactions of Ivosidenib (Tibsovo)
    What Are the Precautions for Using Ivosidenib (Tibsovo)?
    Dosage and Administration, Recommended Dosage of Ivosidenib (Tibsovo)
    What Are the Indications for Ivosidenib (Tibsovo)?
    What Are the Purchase Channels for Ivosidenib (Tibsovo)?
    Adverse Reactions of Sitagliptin/Metformin Extended-Release Tablets (Janumet XR)
    What are the Precautions for Using Sitagliptin/Metformin Extended-Release Tablets (Janumet XR)?
    New Drugs
    Infigratinib(Truseltiq)
    Infigratinib(Truseltiq)
    Treatment of previously treated, unresectable locally advanced or metastatic...
    Opicapone(Ongentys)
    Opicapone(Ongentys)
    Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
    Deflazacort(Emflaza)
    Deflazacort(Emflaza)
    Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
    Faricimab-svoa(Vabysmo)
    Faricimab-svoa(Vabysmo)
    Treatment of neovascular age-related macular degeneration, diabetic macular...
    Counselling Service
    Global Drug Search
    Clinical Research Recruitment
    Overseas Medical Treatment
    Remote Consultations
    Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
    Submit
    Product
    Business
    • Core products
    • Antitumor drugs
    • General drug
    • Antiviral drugs
    • Biological agents
    Contact Us 
    • mailbox：info@lucius.la
    Welcome to consult
    ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved